FNDC5 and metabolic dysfunction-associated steatotic liver disease: Polyzos et al. [35] also found that serum irisin levels were significantly decreased in patients with NAFLD and non-alcoholic steatohepatitis (NASH) compared with lean controls, but do not differ between patients with NAFLD and NASH.